- Current challenge of TBI heterogeneity
- Secondary injury as a primary target
- SUR1-TRPM4 as a potential pathway that can be manipulated (exemplar)
- Future horizons (single-cell sequencing, genetics, multimodality monitoring, integration). 

Session date: 
08/21/2024 - 8:00am to 9:00am CDT
Location: 
UT Southwestern Medical Center
D1.602
Dallas, TX
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA
  • 1.00 Attendance

Please login or create an account to take this course.